Snyder David S
- SEC CIK
- 0001398625
No open-market purchases or sales filed in the past year.
Current role at each company
- COYA Coya Therapeutics, Inc.Chief Financial Officeras of Jan 26, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Snyder David S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2024 (view filing) | Nov 14 | Same day | Snyder David SChief Financial Officer | PPurchaseCommon Stock, par value $0.0001 per share | +1.80K | $7.19 | +$12.9K | +25.7%8.80K after | |
| Jan 4, 2023 (view filing) | Jan 3 | 1 day | Snyder David SChief Financial Officer | PPurchaseCommon Stock, par value $0.0001 per share | +7.00K | – | – | New position7.00K after | |
| Jan 4, 2023 (view filing) | Jan 3 | 1 day | Snyder David SChief Financial Officer | PPurchaseCommon Stock, par value $0.0001 per share | +3.50K | – | – | –3.50K after | Derivative |